top of page
Executive Spotlights

Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines

La Jolla, CA, October 24, 2023 (Business Wire) -- Rampart Bioscience, Inc., a biotechnology firm dedicated to the advancement of next-generation announces an $85 million Series A financing. It is focused on medical solutions that alleviate the burdens imposed by disease and conventional treatments.


Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial

Comments


Life Science Headlines
bottom of page